Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Trial will assess antibody response in people who did not respond to two-dose regimen.
Researchers reached this conclusion after reviewing data on more than 30,000 people.
The experimental surgeries could help open up an entirely new pool of donor organs for those in need of a transplant.
The generally well-tolerated regimen cured all transplantees with genotype 1 or 4 of hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.